Home Cart Sign in  
Chemical Structure| 1221186-53-3 Chemical Structure| 1221186-53-3

Structure of TEPP-46
CAS No.: 1221186-53-3

Chemical Structure| 1221186-53-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TEPP-46 is a potent and selective activator of recombinant pyruvate kinase M2 (PKM2) with half-maximum activating concentration (AC50 value) of 92 nM, and has little or no effect on PKM1, PKL and PKR.

Synonyms: ML-265; CID-44246499; NCGC00186528

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TEPP-46

CAS No. :1221186-53-3
Formula : C17H16N4O2S2
M.W : 372.46
SMILES Code : O=C1C(N(C)C2=C3SC(S(C)=O)=C2)=C3C=NN1CC4=CC=CC(N)=C4
Synonyms :
ML-265; CID-44246499; NCGC00186528
MDL No. :MFCD23160747
InChI Key :ZWKJWVSEDISQIS-UHFFFAOYSA-N
Pubchem ID :44246499

Safety of TEPP-46

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
TEPP-46 (ML-265) is an effective and specific activator of pyruvate kinase M2 (PKM2), demonstrating an AC50 of 92 nM, while showing minimal to no impact on PKM1, PKL, and PKR[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
Human pulmonary artery fibroblasts 100 µM 72 hours TEPP-46 treatment stabilized the PKM2 tetramer, decreased lactate production, and corrected metabolic abnormalities in PH-Fibs, while also reducing cell proliferation. PMC5973494
human primary vascular smooth muscle cells (VSMCs) 20 µmol/L 24 hours TEPP-46 significantly increased PKM2 enzyme activity and reversed the inhibitory effects of GMRSP on PDGF-BB-induced VSMC migration and μMP2 secretion. PMC11836370
HFL1 cells 10 μM 24 hours TEPP-46 slightly increased the levels of p-Smad3 and the profibrotic factors α-SMA and Fn PMC9491720
BMDMs 50 μM 24 hours TEPP-46 inhibited LPS-induced nuclear translocation of PKM2 and reduced the expression of IL-1β and Ldha. PMC5198835
RAW 264.7 macrophages 10 μM 1 hour TEPP-46 promoted tetramer formation of PKM2 and reduced the presence of smaller molecular weight complexes. PMC5198835
MDA-MB-231 cells 5 μM 24 hours After TEPP-46 treatment, the oligomeric state of PKM2 shifted from monomer/dimer to dimer/tetramer, with PKM2pS37 present in different oligomeric states. PMC8373815
MDA-MB-231 cells 10 μM 20 hours TEPP-46 treatment reduced the nuclear localization of both PKM2pS37 and total PKM2, but did not significantly affect apoptosis or redox balance. PMC8373815

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice BAPN monofumarate-induced aortic dissection model oral gavage 10 mg/kg, twice daily Twice daily for 14 days TEPP-46 reversed the protective effect of GMRSP on BAPN monofumarate-induced aortic dissection, increasing vascular injury, dissection incidence, and mortality. PMC11836370
mice BLM-induced pulmonary fibrosis model oral gavage 10 mg/kg/d Once daily for 4 weeks The TEPP-46-treated group showed more severe pathological changes and collagen deposition compared to the control group PMC9491720
Mice LPS-induced sepsis model Intraperitoneal injection 10 mg/kg once daily for four weeks TEPP-46 significantly reduced LPS-induced IL-1β production while boosting IL-10 production. PMC5198835
mice TNBC xenograft model intraperitoneal injection 30 mg/kg once daily for 7 days TEPP-46 treatment significantly reduced tumor growth and decreased the expression and nuclear localization of PKM2pS37 in tumors. PMC8373815
Mice Lkb1flox/flox;Myh11-Cre/ERT2 mice Intraperitoneal injection 50 mg/kg Single dose, lasting 2 hours TEPP-46 activation of PKM2 rescues VSMC transformation and aortic dilation in Lkb1flox/flox;Myh11-Cre/ERT2 mice, maintaining the contractile phenotypes of VSMCs. PMC11587553
Mice C57BL/6J mice Oral 40 mg/kg daily for two weeks To evaluate the effect of TEPP-46 on tumor growth, results showed that TEPP-46 inhibited tumor growth. PMC8591543

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.68mL

0.54mL

0.27mL

13.42mL

2.68mL

1.34mL

26.85mL

5.37mL

2.68mL

References

 

Historical Records

Categories